FIELD: medicine, narcology. SUBSTANCE: invention relates to the use of some pyridyl- and pyrimidyl-piperazines substituted at position 1 of piperazine ring with arylalkyl, arylhydroxyalkyl or arylthioalkyl group and showing efficiency in treatment of diseases induced by narcotic agents addiction. Invention provides the expanded assortment of psychotropic agents eliciting high affinity both to 5-NT1A- and 5-HT2-receptors and showing from weak to moderate 5-HT- inhibiting effect in repeated administration. EFFECT: enhanced effectiveness of agents. 6 cl, 2 tbl
Authors
Dates
2003-01-27—Published
1997-04-22—Filed